CB
Christophe Bourdon
Making a fundamental difference in Medical Dermatology as CEO of LEO Pharma
Sobi - Swedish Orphan Biovitrum AB (publ)•Stockholm, Stockholm County, Sweden
View LinkedIn ProfileExperience35+ Years
LevelLeadership
Career Timeline
- Apr 2023–Present· 3 yrs 5 mos
- Member, Management BoardCurrentApr 2023–Present
- LEO PharmaCurrentApr 2022–Present· 4 yrs 5 mos
- Chief Executive Officer, LEO PharmaCurrentApr 2022–Present
- Mar 2021–Feb 2022· 11 mos
- Chief Executive OfficerMar 2021–Feb 2022
- 2018–Mar 2021· 3 yrs 2 mos
- Senior Vice President, General Manager, U.S. Oncology BusinessAug 2020–Mar 2021
- Vice President, General Manager, U.S. Oncology Business2018–Aug 2020
- 2015–Nov 2017· 2 yrs 10 mos
- Senior Vice President EMEACSep 2015–Nov 2017
- Vice President, Midsize Markets EMEA2015–Sep 2015
- 2007–Dec 2014· 7 yrs 11 mos
- Vice President & General Manager, GermanySep 2013–Dec 2014
- General Manager, Central & Eastern Europe2011–Aug 2013
- Executive Director BU Oncology/Hematology, FranceSep 2008–Dec 2010
- Director Sales & Marketing Effectiveness, France2007–Aug 2008
- 2005–Dec 2006· 1 yr 11 mos
- Director, Corporate Marketing2005–Dec 2006
- 1999–Dec 2004· 5 yrs 11 mos
- General Manager NorwaySep 2003–Dec 2004
- Product Manager CardiovascularJul 2001–Aug 2003
- Sales Representative, FranceSep 2000–Jun 2001
- Chief of Staff, Chief Executive Officer1999–Aug 2000
- Aug 1993–Dec 1997· 4 yrs 4 mos
- Financial Controller, JapanAug 1993–Dec 1997
- Jun 1991–Aug 1993· 2 yrs 2 mos
- French Civil Service (''VIE"), JapanJun 1991–Aug 1993
Education
Master Business Administration
IMDBusiness Degree
ISG Institut Supérieur de GestionExecutive Relationship Map
Reports To
Christophe Bourdon
Vice Chair & President
Chief Financial Officer
Chief Technology Officer
Chief Operating Officer
Skills & Expertise
FrenchJapaneseGermanProduct LaunchOncologyFull P&L ResponsibilityLife SciencesBiopharmaceuticalsStrategyCross-functional Team LeadershipBusiness StrategyEnglishClinical DevelopmentClinical TrialsPharmaceutical SalesOperations ManagementPharmaceutical IndustryLifesciencesBiotechnologyMarket Access